|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yugawa T and Kiyono T: Molecular
mechanisms of cervical carcinogenesis by high-risk human
papillomaviruses: Novel functions of E6 and E7 oncoproteins. Rev
Med Virol. 19:97–113. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Latsuzbaia A, Tapp J, Nguyen T, Fischer M,
Arbyn M, Weyers S and Mossong J: Analytical performance evaluation
of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical
samples. Diagn Microbiol Infect Dis. 85:318–322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tang A, Dadaglio G, Oberkampf M, Di Carlo
S, Peduto L, Laubreton D, Desrues B, Sun CM, Montagutelli X and
Leclerc C: B cells promote tumor progression in a mouse model of
HPV-mediated cervical cancer. Int J Cancer. 139:1358–1371. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chatzistamatiou K, Moysiadis T, Moschaki
V, Panteleris N and Agorastos T: Comparison of cytology, HPV DNA
testing and HPV 16/18 genotyping alone or combined targeting to the
more balanced methodology for cervical cancer screening. Gynecol
Oncol. 142:120–127. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Scotto L, Narayan G, Nandula SV,
Subramaniyam S, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M,
Schneider A, Arias-Pulido H, et al: Integrative genomics analysis
of chromosome 5p gain in cervical cancer reveals target
over-expressed genes, including Drosha. Mol Cancer. 7:582008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dowen SE, Neutze DM, Pett MR, Cottage A,
Stern P, Coleman N and Stanley MA: Amplification of chromosome 5p
correlates with increased expression of Skp2 in HPV-immortalized
keratinocytes. Oncogene. 22:2531–2540. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ron D and Mochly-Rosen D: Agonists and
antagonists of protein kinase C function, derived from its binding
proteins. J Biol Chem. 269:21395–21398. 1994.PubMed/NCBI
|
|
9
|
McCahill A, Warwicker J, Bolger GB,
Houslay MD and Yarwood SJ: The RACK1 scaffold protein: A dynamic
cog in cell response mechanisms. Mol Pharmacol. 62:1261–1273. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Peng R, Jiang B, Ma J, Ma Z, Wan X, Liu H,
Chen Z, Cheng Q and Chen R: Forced downregulation of RACK1 inhibits
glioma development by suppressing Src/Akt signaling activity. Oncol
Rep. 30:2195–2202. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu J, Meng J, Du Y, Huang Y, Jin Y, Zhang
J, Wang B, Zhang Y, Sun M and Tang J: RACK1 promotes the
proliferation, migration and invasion capacity of mouse
hepatocellular carcinoma cell line in vitro probably by PI3K/Rac1
signaling pathway. Biomed Pharmacother. 67:313–319. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shi S, Deng YZ, Zhao JS, Ji XD, Shi J,
Feng YX, Li G, Li JJ, Zhu D, Koeffler HP, et al: RACK1 promotes
non-small-cell lung cancer tumorigenicity through activating sonic
hedgehog signaling pathway. J Biol Chem. 287:7845–7858. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yong-Zheng X, Wan-Li M, Ji-Ming M and
Xue-Qun R: Receptor for activated protein kinase C 1 suppresses
gastric tumor progression through nuclear factor-κB pathway. Indian
J Cancer. 52(Suppl 3): E172–E175. 2015. View Article : Google Scholar
|
|
14
|
Chen L, Min L, Wang X, Zhao J, Chen H, Qin
J, Chen W, Shen Z, Tang Z, Gan Q, et al: Loss of RACK1 promotes
metastasis of gastric cancer by inducing a miR-302c/IL8 signaling
loop. Cancer Res. 75:3832–3841. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Xiao Y, Fan S, Xiao M, Wang X, Chen
X, Li C, Zong G, Zhou G and Wan C: RACK1 overexpression associates
with pancreatic ductal adenocarcinoma growth and poor prognosis.
Exp Mol Pathol. 101:176–186. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng H, Gong PG, Li JB, Cai LM, Yang L,
Liu YY, Yao KT and Li X: The important role of the receptor for
activated C kinase 1 (RACK1) in nasopharyngeal carcinoma
progression. J Transl Med. 14:1312016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu F, Tao Z, Wang M, Li G, Zhang Y, Zhong
H, Xiao H, Xie X and Ju M: RACK1 promoted the growth and migration
of the cancer cells in the progression of esophageal squamous cell
carcinoma. Tumour Biol. 34:3893–3899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu F, Zhang C, Wu WJ and Wu YM: RACK1
downregulation suppresses migration and proliferation of
neuroblastoma cell lines. Oncol Rep. 27:1646–1652. 2012.PubMed/NCBI
|
|
19
|
Ruan Y, Sun L, Hao Y, Wang L, Xu J, Zhang
W, Xie J, Guo L, Zhou L, Yun X, et al: Ribosomal RACK1 promotes
chemoresistance and growth in human hepatocellular carcinoma. J
Clin Invest. 122:2554–2566. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao X, Xue A, Fang Y, Shu P, Ling J, Hou
Y, Shen K, Qin J, Sun Y and Qin X: RACK1 overexpression is linked
to acquired imatinib resistance in gastrointestinal stromal tumor.
Oncotarget. 7:14300–14309. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Z, Zhang B, Jiang L, Zeng X, Chen Y,
Feng X, Guo Y and Chen Q: RACK1, an excellent predictor for poor
clinical outcome in oral squamous carcinoma, similar to Ki67. Eur J
Cancer. 45:490–496. 2009. View Article : Google Scholar
|
|
22
|
Li JJ and Xie D: RACK1, a versatile hub in
cancer. Oncogene. 34:1890–1898. 2015. View Article : Google Scholar
|
|
23
|
Zhong X, Li M, Nie B, Wu F, Zhang L, Wang
E and Han Y: Overexpressions of RACK1 and CD147 associated with
poor prognosis in stage T1 pulmonary adenocarcinoma. Ann Surg
Oncol. 20:1044–1052. 2013. View Article : Google Scholar
|
|
24
|
Nagashio R, Sato Y, Matsumoto T, Kageyama
T, Satoh Y, Shinichiro R, Masuda N, Goshima N, Jiang SX and Okayasu
I: Expression of RACK1 is a novel biomarker in pulmonary
adenocarcinomas. Lung Cancer. 69:54–59. 2010. View Article : Google Scholar
|
|
25
|
Guo Y, Wang W, Wang J, Feng J, Wang Q, Jin
J, Lv M, Li X, Li Y, Ma Y, et al: Receptor for activated C kinase 1
promotes hepatocellular carcinoma growth by enhancing
mitogen-activated protein kinase kinase 7 activity. Hepatology.
57:140–151. 2013. View Article : Google Scholar
|
|
26
|
Deng YZ, Yao F, Li JJ, Mao ZF, Hu PT, Long
LY, Li G, Ji XD, Shi S, Guan DX, et al: RACK1 suppresses gastric
tumorigenesis by stabilizing the β-catenin destruction complex.
Gastroenterology. 142:812–823.e15. 2012. View Article : Google Scholar
|
|
27
|
Mamidipudi V, Dhillon NK, Parman T, Miller
LD, Lee KC and Cartwright CA: RACK1 inhibits colonic cell growth by
regulating Src activity at cell cycle checkpoints. Oncogene.
26:2914–2924. 2007. View Article : Google Scholar
|
|
28
|
Liao S, Xiao S, Zhu G, Zheng D, He J, Pei
Z, Li G and Zhou Y: CD38 is highly expressed and affects the
PI3K/Akt signaling pathway in cervical cancer. Oncol Rep.
32:2703–2709. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hara A and Okayasu I: Cyclooxygenase-2 and
inducible nitric oxide synthase expression in human astrocytic
gliomas: Correlation with angiogenesis and prognostic significance.
Acta Neuropathol. 108:43–48. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin Y, Cui M, Teng H, Wang F, Yu W and Xu
T: Silencing the receptor of activated C-kinase 1 (RACK1)
suppresses tumorigenicity in epithelial ovarian cancer in vitro and
in vivo. Int J Oncol. 44:1252–1258. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shen F, Yan C, Liu M, Feng Y and Chen Y:
RACK1 promotes prostate cancer cell proliferation, invasion and
metastasis. Mol Med Rep. 8:999–1004. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J, Guo Y, Feng X, Wang Z, Wang Y, Deng
P, Zhang D, Wang R, Xie L, Xu X, et al: Receptor for activated C
kinase 1 (RACK1): A regulator for migration and invasion in oral
squamous cell carcinoma cells. J Cancer Res Clin Oncol.
138:563–571. 2012. View Article : Google Scholar
|
|
33
|
Dave JM, Kang H, Abbey CA, Maxwell SA and
Bayless KJ: Proteomic profiling of endothelial invasion revealed
receptor for activated C kinase 1 (RACK1) complexed with vimentin
to regulate focal adhesion kinase (FAK). J Biol Chem.
288:30720–30733. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gandin V, Senft D, Topisirovic I and Ronai
ZA: RACK1 function in cell motility and protein synthesis. Genes
Cancer. 4:369–377. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu B, Wang C, Chen P, Wang L and Cheng Y:
RACK1 promotes radiation resistance in esophageal cancer via
regulating AKT pathway and Bcl-2 expression. Biochem Biophys Res
Commun. 491:622–628. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fei L, Ma Y, Zhang M, Liu X, Luo Y, Wang
C, Zhang H, Zhang W and Han Y: RACK1 promotes lung cancer cell
growth via an MCM7/RACK1/Akt signaling complex. Oncotarget.
8:40501–40513. 2017.PubMed/NCBI
|
|
37
|
Zhou C, Chen T, Xie Z, Qin Y, Ou Y, Zhang
J, Li S, Chen R and Zhong N: RACK1 forms a complex with FGFR1 and
PKM2 and stimulates the growth and migration of squamous lung
cancer cells. Mol Carcinog. Apr 18–2017.Epub ahead of print.
View Article : Google Scholar
|
|
38
|
Wang Q, Zhou S, Wang JY, Cao J, Zhang X,
Wang J, Han K, Cheng Q, Qiu G, Zhao Y, et al: RACK1 antagonizes
TNF-α-induced cell death by promoting p38 activation. Sci Rep.
5:142982015. View Article : Google Scholar
|
|
39
|
Diaz-Moralli S, Tarrado-Castellarnau M,
Miranda A and Cascante M: Targeting cell cycle regulation in cancer
therapy. Pharmacol Ther. 138:255–271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Williams GH and Stoeber K: The cell cycle
and cancer. J Pathol. 226:352–364. 2012. View Article : Google Scholar
|
|
41
|
Aarts M, Linardopoulos S and Turner NC:
Tumour selective targeting of cell cycle kinases for cancer
treatment. Curr Opin Pharmacol. 13:529–535. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Schafer KA: The cell cycle: A review. Vet
Pathol. 35:461–478. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Waga S, Li R and Stillman B: p53-induced
p21 controls DNA replication. Leukemia. 11(Suppl 3): 321–323.
1997.PubMed/NCBI
|
|
45
|
Harper JW, Elledge SJ, Keyomarsi K,
Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley
L and Swindell E: Inhibition of cyclin-dependent kinases by p21.
Mol Biol Cell. 6:387–400. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Besson A, Dowdy SF and Roberts JM: CDK
inhibitors: Cell cycle regulators and beyond. Dev Cell. 14:159–169.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li D, Dai C, Yang X, Wang F, Yu X and Xiao
X: Tang S. Critical role of p21 on olaquindox-induced mitochondrial
apoptosis and S-phase arrest involves activation of PI3K/AKT and
inhibition of Nrf2/HO-1 pathway. Food Chem Toxicol. 108:148–160.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kim HS and Lee MS: STAT1 as a key
modulator of cell death. Cell Signal. 19:454–465. 2007. View Article : Google Scholar
|
|
49
|
Zhang Y, Zhang Y, Yun H, Lai R and Su M:
Correlation of STAT1 with apoptosis and cell-cycle markers in
esophageal squamous cell carcinoma. PLoS One. 9:e1139282014.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Townsend PA, Scarabelli TM, Davidson SM,
Knight RA, Latchman DS and Stephanou A: STAT-1 interacts with p53
to enhance DNA damage-induced apoptosis. J Biol Chem.
279:5811–5820. 2004. View Article : Google Scholar
|
|
51
|
Aggarwal BB: Tumour necrosis factors
receptor associated signalling molecules and their role in
activation of apoptosis, JNK and NF-kappaB. Ann Rheum Dis. 59(Suppl
1): i6–i16. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: A basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Perkins ND: The diverse and complex roles
of NF-κB subunits in cancer. Nat Rev Cancer. 12:121–132.
2012.PubMed/NCBI
|
